Newsroom | 11949 results

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking the company’s proposed acquisition of JenaValve Technology. As a result, Edwards will not acquire JenaValve. Edwards disagrees with the decision and believes that the acquisition would have been in the best interest of a large, growing and underserved group of pati...

JUPITER, Fla.--(BUSINESS WIRE)--Jupiter Medical Center (JMC) and Hospital for Special Surgery (HSS) are teaming up to expand access to the highest quality musculoskeletal care in South Florida. The alliance brings together Jupiter Medical Center, the region’s leading independent medical center, and HSS, ranked No. 1 in orthopedics by U.S. News & World Report for 16 straight years. Together, they will offer patients comprehensive orthopedic care—from diagnosis and surgery to rehabilitation—d...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the company has been acquired by Haemonetics Corporation (NYSE: HAE) in a transaction valued up to €185M (~$215M) on completion of certain milestones. Based in Galway, Ireland, Vivasure is focused on the development of advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology,...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026. CONMED has initiated a comprehensive search process, supported by a leading executive search firm, to identify its next Chief Financial Officer. “On behalf of our Board and leadership team, I...

SAN ANTONIO--(BUSINESS WIRE)--IVF Academy USA today announced the appointment of Chris Flynn, RN as director of Nursing Programs, where she will lead the development and expansion of structured, simulation-based education pathways designed specifically for aspiring fertility nurses. The appointment comes at a pivotal time, as both nationwide nursing shortages and the rapid rise in demand for assisted reproductive technologies (ART) have created a bottleneck in fertility care. IVF Academy USA’s...

DARIEN, Conn.--(BUSINESS WIRE)--The Vascular Care Group (TVCG), the largest independent group of board-certified vascular specialists in the United States, today announced the launch of TVCG CARES International, the Center for Anomalies and Rare Entities, along with the debut of its dedicated patient and physician website: www.tvcgcares.com. Founded and led by Dr. Naiem Nassiri, a nationally and internationally recognized vascular and endovascular surgeon, TVCG CARES International is a comprehe...

CLINTON, Mo.--(BUSINESS WIRE)--Golden Valley Memorial Healthcare (GVMH) is earning national recognition for excellence in orthopedic innovation as James Womack, MD, Orthopedic Surgeon, has been published in the Journal of Experimental Orthopaedics for his pioneering work with a next-generation handheld robotic system designed for total knee arthroplasty (TKA). This peer-reviewed study, “A Novel Handheld Wireless Robot for Total Knee Arthroplasty: Early Experiences and Clinical Results,” present...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the selection of AMX0318, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist, as a development candidate for post-bariatric hypoglycemia (PBH) and other rare diseases. AMX0318 was identified through a research collaboration with Gubra A/S (“Gubra”), a company specializing in peptide-based drug discovery and preclinical contract research services. “We are very...

LEBANON, N.H.--(BUSINESS WIRE)--Cairn Surgical completes enrollment in its U.S. pivotal trial of the Breast Cancer Locator System designed to improve the precision of tumor removal....

BONITA SPRINGS, Fla.--(BUSINESS WIRE)--Curadel's novel targeted zwitterionic surgical imaging drug for pancreatic cancer has been granted Orphan Drug Designation by the FDA and the EMA....